A candidate receptor underlying serotonin effects in ALS is the 5-HT2BR. Indeed, Htr2b expression was upregulated in the spinal cord of Sod1G86R mouse model of ALS at pre-symptomatic stage9, and its deletion worsened disease outcome in this model. This evidence concerns the gene HTR2B and amyotrophic lateral sclerosis.